Polaryx Therapeutics Inc (PLYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,924 | -2,544 | -8,985 | -6,060 | -5,052 |
| Accounts payable and accrued liabilities | 213 | 380 | N/A | 86 | -17 |
| Other Working Capital | 25 | 14 | 316 | -67 | -108 |
| Other Operating Activity | 254 | 87 | 4,725 | 4,474 | 4,468 |
| Operating Cash Flow | $-3,432 | $-2,063 | $-3,944 | $-1,567 | $-709 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,831 | N/A | N/A | 250 | 250 |
| Other Financing Activity | 0 | 0 | 4,466 | 0 | 0 |
| Financing Cash Flow | $9,831 | $N/A | $4,466 | $250 | $250 |
| Beginning Cash Position | 5,143 | 5,143 | 4,621 | 4,621 | 4,621 |
| End Cash Position | 11,542 | 3,080 | 5,143 | 3,304 | 4,162 |
| Net Cash Flow | $6,399 | $-2,063 | $522 | $-1,317 | $-459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,432 | -2,063 | -3,944 | -1,567 | -709 |
| Free Cash Flow | -3,432 | -2,063 | -3,944 | -1,567 | -709 |